Načítá se...
Donor: Recipient ABO mismatch does not impact outcomes of allogeneic hematopoietic cell transplantation regardless of graft source
The impact of ABO mismatch has been studied on various hematopoietic cell transplant (HCT) outcomes including neutrophil and platelet engraftment, pure red cell aplasia (PRCA), acute and chronic GVHD, non-relapse mortality (NRM) and overall survival (OS). Yet conflicting results have been reported....
Uloženo v:
| Vydáno v: | Biol Blood Marrow Transplant |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5744261/ https://ncbi.nlm.nih.gov/pubmed/28232088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2017.02.009 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|